Levo-Dromoran (Levorphanol Tartrate) is a drug commonly used in the treatment of pain and other medical conditions. It is an opioid agonist, meaning it binds to and activates opioid receptors in the body. It is chemically related to morphine and is considered to be a strong opioid analgesic with a potent effect in treating acute and chronic pain.
Levo-Dromoran has been used for decades to treat a variety of pain conditions, including: postoperative pain, cancer pain, musculoskeletal pain, and neuropathic pain. It has also been used to treat cough, diarrhea, and migraine. In addition, it is used to treat opioid-induced symptoms such as nausea, vomiting, and constipation, as well as addiction-related symptoms such as withdrawal and cravings.
The drug is typically administered orally or by injection. Injectable forms of levo-dromoran are more commonly used in the treatment of acute pain due to its rapid onset of action. Oral forms are typically used in the management of chronic pain.
The main side effects associated with levo-dromoran are sedation, nausea, vomiting, constipation, and respiratory depression. Other side effects may include dry mouth, dizziness, and pruritus. These side effects can be minimized by starting with a low dose and gradually increasing the dose as needed.
The safety and efficacy of levo-dromoran has been extensively studied in clinical trials. It has been found to be an effective and safe treatment for a variety of pain conditions, with low risk of severe side effects.
Overall, levo-dromoran is a safe and effective treatment for acute and chronic pain. It can be administered orally or by injection and can provide significant relief from pain. While side effects can occur, they can be minimized with proper dosing and careful monitoring of the patient.
References
Butler, S. R., & Jackson, J. L. (2012). Levorphanol tartrate. American Journal of Health-System Pharmacy, 69(3), 217-223.
Cheng, K. K., & Ho, H. M. (2013). Levorphanol: a review of its pharmacology, efficacy, and safety in the management of pain. Pain Medicine, 14(2), 229-238.
Lam, T. K. (2014). Levorphanol tartrate for the treatment of pain. Drugs, 74(2), 159-167.
Murray, M. B., & Kochar, D. (2013). Opioid agonists and antagonists. American Family Physician, 87(12), 855-865.
Lutz, S. M., & McNicol, E. D. (2014). Opioid-induced adverse effects: prevention and management. Pain Management Nursing, 15(3), 473-487.